About Technology Issues FAQ

Links

mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents

mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.